Nagoya Protocol Compliance in Botanical Sourcing
- Yishai Nissan
- Jul 7, 2025
- 4 min read
What Is the Nagoya Protocol and Why Should You Care?
The Nagoya Protocol is an international agreement under the Convention on Biological Diversity that governs access to genetic resources and the fair sharing of benefits arising from their use. Adopted in 2010 and entering into force in 2014, it establishes a legal framework requiring that biological materials sourced from signatory countries are obtained with prior informed consent and that benefits from their commercial use are shared equitably with the country of origin.
In practical terms, it means that any company using plant-based raw materials originating from a signatory country must demonstrate that those materials were obtained with proper authorization and that benefit-sharing obligations have been met. For botanical ingredient buyers, this creates a direct compliance obligation that extends through the entire supply chain.
For R&D teams and procurement departments sourcing botanical ingredients, this is not an abstract legal concept. Since the EU implemented the Nagoya Protocol through Regulation No. 511/2014, companies utilizing genetic resources in research and development must exercise "due diligence" to ensure compliance. Non-compliance can result in administrative penalties, product recalls, and reputational damage. Several EU member states have already begun enforcement actions, making this a present-day risk, not a future concern.
Who Is Affected and When?
The Nagoya Protocol’s due diligence obligations are triggered specifically when genetic resources are used in "research and development," as defined under the Convention on Biological Diversity. This definition is broad. It covers not only pharmaceutical drug discovery but also cosmetic ingredient development, nutraceutical formulation, and any process where the biochemical properties of a plant material are studied or utilized to develop new products or applications.
This means that virtually every BotaniX client, whether developing a new skincare formulation, screening botanical extracts for bioactivity, or optimizing an existing nutraceutical product, is operating within the scope of Nagoya obligations when using internationally sourced plant materials. The compliance trigger is the R&D activity itself, not the final product category.
Companies must be able to demonstrate, through documentation, that they have identified the country of origin of their genetic resources, determined whether that country is a Nagoya Protocol signatory, verified that access was obtained in accordance with applicable national legislation, and established that benefit-sharing terms are in place. This documentation must be maintained and made available to competent authorities upon request.
The Compliance Challenge in Traditional Sourcing
Most botanical raw materials are sourced from Asia, Africa, or South America through complex multi-intermediary supply chains that may involve collectors, consolidators, primary processors, exporters, and multiple trading intermediaries before the material reaches a European buyer. Tracing the origin of a plant extract back to the specific country and collection site, and verifying that access and benefit-sharing agreements are in place at every step, can be extremely difficult in practice.
Many traditional suppliers cannot provide the documentation required under EU regulations, leaving the buyer exposed to compliance risk. In some cases, the original collection sites may span multiple countries, or the material may have been aggregated from various sources, making it practically impossible to establish a clear chain of custody. For procurement teams, this creates a dilemma: either invest significant resources in compliance verification for each supplier and each botanical, or accept a level of legal risk that may be untenable.
This risk is amplified when companies use botanicals in R&D for new product development, which is precisely the context in which most BotaniX clients operate. A single non-compliant ingredient can jeopardize an entire product launch, with financial consequences that far exceed the cost of the raw material itself.
The Broader Regulatory Context: CSRD and Supply Chain Due Diligence
The Nagoya Protocol does not exist in isolation. The EU’s Corporate Sustainability Reporting Directive (CSRD), which began phased implementation in 2024, requires companies to report on the sustainability of their supply chains, including biodiversity impacts and resource sourcing practices. The EU Corporate Sustainability Due Diligence Directive (CSDDD) further extends accountability by requiring companies to identify, prevent, and mitigate adverse impacts throughout their value chains.
Together, these regulatory instruments create a converging compliance landscape where botanical ingredient sourcing is subject to multiple overlapping obligations. Companies that source from regions with weak governance or opaque supply chains face compounding regulatory exposure across Nagoya, CSRD, and CSDDD frameworks simultaneously. Addressing each regulation separately is costly and inefficient. The more effective approach is to source from supply chains that are inherently compliant by design.
How BotaniX Eliminates Nagoya Risk
BotaniX cultivates all medicinal plants in controlled indoor environments in France. Our genetic material is sourced through fully documented, compliant channels with complete provenance records, and every plant in our catalog comes with full documentation of origin, access authorization, and compliance status.
Because we control the entire chain from seed acquisition to final ingredient production, there are no intermediaries, no uncertain origins, and no compliance gaps. Our B Corp certification (since 2022) and full Nagoya Protocol adherence are independently verified, not self-declared.
For B2B buyers, sourcing from BotaniX means sourcing with full Nagoya Protocol compliance built into the supply chain, not bolted on as an afterthought. Every shipment arrives with complete documentation that satisfies EU due diligence requirements under Regulation 511/2014. This documentation can be submitted directly to competent authorities if requested, eliminating the compliance burden from your procurement team.
This is particularly valuable for companies subject to CSRD sustainability reporting requirements, which increasingly demand verifiable supply chain transparency as part of corporate due diligence obligations. A single supplier that is Nagoya-compliant, GACP/GMP-certified, B Corp-verified, and European-sourced addresses multiple regulatory requirements simultaneously.
